Assembly Biosciences, Inc.
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd.; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California. Show More...
-
Website http://www.assemblybio.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 14.15 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -123.35 -17.85 -9.7 -5.0 -3.4 -1.81 -2.57 -2.41 -3.98 -3.72 -3.43 Dividends USD Payout Ratio % * Shares Mil 2.0 3.0 4.0 7.0 16.0 17.0 18.0 23.0 26.0 29.0 Book Value Per Share * USD 8.62 21.04 6.88 7.25 4.42 7.28 5.22 2.34 9.0 4.81 7.69 Free Cash Flow Per Share * USD -42.06 -7.34 -8.4 -4.45 -3.11 -1.21 -1.7 -2.76 -3.19 Return on Assets % -206.87 -132.96 -86.08 -81.38 -48.37 -27.76 -38.18 -32.02 -41.5 -32.12 -33.97 Financial Leverage (Average) 1.26 1.07 1.15 1.11 1.21 1.13 1.23 1.5 1.27 1.24 1.24 Return on Equity % -148.81 -94.72 -91.74 -57.28 -32.09 -44.57 -44.36 -56.06 -40.36 -43.98 Return on Invested Capital % -148.7 -94.97 -92.69 -57.68 -33.48 -46.1 -45.2 -57.45 -40.09 -43.35 Interest Coverage -0.45 -291.45 Current Ratio 8.48 14.73 7.48 10.28 27.72 20.09 7.52 9.13 12.05 11.57 12.14 Quick Ratio 8.47 14.71 7.46 10.25 27.6 19.88 7.44 9.06 11.94 11.35 11.93 Debt/Equity 0.11 0.03 0.03